<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Vulvovaginitis in the prepubertal child: Clinical manifestations, diagnosis, and treatment</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Vulvovaginitis in the prepubertal child: Clinical manifestations, diagnosis, and treatment</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Vulvovaginitis in the prepubertal child: Clinical manifestations, diagnosis, and treatment</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Marc R Laufer, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">S Jean Emans, MD</a></dd><dt><span> </span>Section Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Jan E Drutz, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">George A Woodward, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">James F Wiley, II, MD, MPH</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Jul 12, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H291724447"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>This topic will discuss vulvovaginitis in the prepubertal female. The evaluation and management of sexual abuse in the prepubertal child are discussed separately. (See  <a class="medical medical_review" href="/d/html/6605.html" rel="external">"Evaluation of sexual abuse in children and adolescents"</a> and  <a class="medical medical_review" href="/d/html/6607.html" rel="external">"Management and sequelae of sexual abuse in children and adolescents"</a>.)</p><p class="headingAnchor" id="H1662583619"><span class="h1">NONSPECIFIC VULVOVAGINITIS</span></p><p class="headingAnchor" id="H1053583382"><span class="h2">Etiology</span><span class="headingEndMark"> — </span>Nonspecific vulvovaginitis is responsible for a large proportion of vulvovaginitis in prepubertal females [<a href="#rid1">1</a>]. Even in situations in which a bacterial isolate from the vagina or introitus is identified, the etiology of the discharge may not be related to the organism (eg, respiratory flora or enteric bacteria) but rather still considered "nonspecific." Factors that increase the risk of vulvovaginitis in prepubertal children include:</p><p class="bulletIndent1"><span class="glyph">●</span>Lack of labial development</p><p class="bulletIndent1"><span class="glyph">●</span>Thin mucosa due to lack of estrogen</p><p class="bulletIndent1"><span class="glyph">●</span>More alkaline pH (pH 7) than postmenarchal females</p><p class="bulletIndent1"><span class="glyph">●</span>Poor hygiene</p><p class="bulletIndent1"><span class="glyph">●</span>Bubble baths, shampoos, deodorant soaps, or other irritants</p><p class="bulletIndent1"><span class="glyph">●</span>Obesity</p><p class="bulletIndent1"><span class="glyph">●</span>Choice of clothing (leotards, tights, and blue jeans)</p><p class="bulletIndent1"><span class="glyph">●</span>Chronic masturbation activity</p><p class="bulletIndent1"><span class="glyph">●</span>Foreign bodies, primarily toilet paper</p><p class="bulletIndent1"><span class="glyph">●</span>Sexual abuse (see  <a class="medical medical_review" href="/d/html/6605.html" rel="external">"Evaluation of sexual abuse in children and adolescents", section on 'Nonspecific findings'</a>)</p><p></p><p class="headingAnchor" id="H631755698"><span class="h2">Clinical manifestations and diagnosis</span><span class="headingEndMark"> — </span>Nonspecific vulvovaginitis typically presents with complaints of nonspecific mucoid discharge, itching, erythema, rash, and/or odor. A prior history of nonspecific vulvovaginitis in association with upper respiratory infections has been described in some patients. The abrupt onset of a green or purulent vaginal discharge suggests a foreign body or a specific bacterial infection.</p><p>On physical examination, the vulva may be erythematous from occlusive diapers or other irritants, skin dermatosis such as atopic dermatitis or psoriasis, or streptococcal perianal infection.</p><p>The child with a nonspecific etiology for vaginal complaints typically has either no vaginal discharge or scant, white or clear, mucoid discharge. Vulvar irritation and, occasionally, thickening of the clitoral hood secondary to chronic itching/scratching or masturbation may also be present. Signs of poor genital hygiene such as bits of toilet paper and fecal matter around the anus, introitus, and/or vagina may be noted. Diagnosis is made based upon these clinical findings.</p><p class="headingAnchor" id="H1412423558"><span class="h2">Management</span></p><p class="headingAnchor" id="H3645598077"><span class="h3">Initial treatment</span><span class="headingEndMark"> — </span>Hygiene measures  (<a class="graphic graphic_table graphicRef132332" href="/d/graphic/132332.html" rel="external">table 1</a>) are the primary treatment for nonspecific vulvovaginitis. Symptoms resolve in most children within two to three weeks. In addition, for children with recurrent episodes of vulvar and/or perianal itching (especially at night), examine for pinworms and treat empirically, as needed. Treatment of pinworm is discussed separately. (See  <a class="medical medical_review" href="/d/html/5692.html" rel="external">"Enterobiasis (pinworm) and trichuriasis (whipworm)"</a>.)</p><p class="headingAnchor" id="H489375041"><span class="h3">Recurrent or persistent symptoms</span><span class="headingEndMark"> — </span>If, despite appropriate adherence to hygiene measures, the child develops a purulent discharge or bleeding, or symptoms of discharge persist, the possibility of a vaginal foreign body or specific infection should be assessed. Next steps include: </p><p class="bulletIndent1"><span class="glyph">●</span>Re-examination of the genitalia in the knee-chest position  (<a class="graphic graphic_figure graphicRef140085" href="/d/graphic/140085.html" rel="external">figure 1</a>) to see if a vaginal foreign body is present. (See  <a class="medical medical_review" href="/d/html/6450.html" rel="external">"Overview of vulvovaginal conditions in the prepubertal child", section on 'Vaginal foreign body'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>If no foreign body is seen, then appropriate testing for bacterial pathogens should be obtained, which includes a vaginal culture for enteric and respiratory organisms and, in prepubertal females with appropriate indications, testing for sexually transmitted infections (STIs). (See  <a class="medical medical_review" href="/d/html/5908.html" rel="external">"Gynecologic examination of the newborn and child", section on 'How to obtain cultures and other specimens from children'</a> and  <a class="medical medical_review" href="/d/html/6605.html" rel="external">"Evaluation of sexual abuse in children and adolescents", section on 'Prepubertal victims'</a>.)</p><p></p><p class="bulletIndent1">Vaginal pH and microscopy are not useful for evaluating vaginitis in prepubertal females. (See  <a class="medical medical_review" href="/d/html/5908.html" rel="external">"Gynecologic examination of the newborn and child", section on 'Other tests'</a>.)</p><p></p><p class="bulletIndent1">Further treatment is determined by test results:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Positive results</strong> – The approach to treatment of infectious vulvovaginitis by potential pathogen is provided below. (See <a class="local">'Infectious causes'</a> below.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Negative results or mixed flora on vaginal culture </strong>– Although not indicated for most cases of nonspecific vaginal discharge, which resolves with the measures above, antibiotic therapy may hasten the resolution of a purulent vaginal discharge (despite a negative culture for specific infections, such as group A <em>streptococcus</em>) that does not respond to hygiene measures and for which other diagnoses have been excluded. Empiric regimens include a 10-day course of oral <a class="drug drug_pediatric" data-topicid="12631" href="/d/drug information/12631.html" rel="external">amoxicillin</a> or <a class="drug drug_pediatric" data-topicid="12639" href="/d/drug information/12639.html" rel="external">amoxicillin-clavulanate</a>, topical <a class="drug drug_pediatric" data-topicid="12606" href="/d/drug information/12606.html" rel="external">metronidazole</a>, or topical <a class="drug drug_pediatric" data-topicid="13167" href="/d/drug information/13167.html" rel="external">clindamycin</a>.</p><p></p><p class="headingAnchor" id="H185494781"><span class="h3">Chronic discharge</span><span class="headingEndMark"> — </span>Prepubertal females with chronic discharge and no clear etiology despite appropriate testing and empiric treatment warrant referral to a pediatric gynecologist or other pediatric specialist with similar expertise for further evaluation. Chronic discharge with or without bleeding may be caused by a vaginal foreign body not visible on physical examination as well as benign or malignant vaginal tumors. (See  <a class="medical medical_review" href="/d/html/6450.html" rel="external">"Overview of vulvovaginal conditions in the prepubertal child"</a>.)</p><p></p><p class="headingAnchor" id="H55905643"><span class="h1">INFECTIOUS CAUSES</span></p><p class="headingAnchor" id="H1407268355"><span class="h2">Etiology</span><span class="headingEndMark"> — </span>Children may pass respiratory flora from the nose and oral pharynx to the vulvar area. Similarly, enteric flora from the anal area can be identified in vaginal cultures from females with vaginitis as well as in asymptomatic controls. Thus, the challenge for clinicians is to determine whether the bacteria found on cultures represent pathogens causing infection or are part of the vaginal flora in a young female presenting with symptoms.</p><p>Respiratory and enteric bacteria cultured in prepubertal females with vulvovaginitis include [<a href="#rid2">2-5</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Respiratory bacteria</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><em>Streptococcus pyogenes</em> (group A <em>streptococcus</em>)</p><p class="bulletIndent2"><span class="glyph">•</span><em>Staphylococcus aureus</em></p><p class="bulletIndent2"><span class="glyph">•</span><em>Haemophilus influenzae</em></p><p class="bulletIndent2"><span class="glyph">•</span><em>Streptococcus pneumoniae</em></p><p class="bulletIndent2"><span class="glyph">•</span><em>Neisseria meningitidis</em></p><p class="bulletIndent2"><span class="glyph">•</span><em>Moraxella catarrhalis</em></p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Enteric bacteria</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><em>Escherichia coli</em></p><p class="bulletIndent2"><span class="glyph">•</span><em>Enterococcus faecalis</em></p><p class="bulletIndent2"><span class="glyph">•</span><em>Klebsiella pneumoniae</em></p><p class="bulletIndent2"><span class="glyph">•</span><em>Proteus mirabilis</em></p><p class="bulletIndent2"><span class="glyph">•</span><em>Pseudomonas</em> species</p><p class="bulletIndent2"><span class="glyph">•</span><em>Shigella</em> species</p><p class="bulletIndent2"><span class="glyph">•</span><em>Yersinia</em> species</p><p></p><p>Less commonly, vulvovaginitis results from sexual contact. Positive testing for sexually transmitted infections (STIs) raises concern for sexual abuse, and additional evaluation is necessary. (See  <a class="medical medical_review" href="/d/html/6605.html" rel="external">"Evaluation of sexual abuse in children and adolescents", section on 'Prepubertal victims'</a> and  <a class="medical medical_review" href="/d/html/6605.html" rel="external">"Evaluation of sexual abuse in children and adolescents", section on 'Sexually transmitted infections'</a>.)</p><p>Although sometimes isolated, <em>Candida</em> species and <em>Gardnerella vaginalis</em> are not usually associated with vulvovaginitis in prepubertal females. (See <a class="local">'Candida'</a> below and <a class="local">'Gardnerella vaginalis'</a> below.)</p><p class="headingAnchor" id="H198359626"><span class="h2">Clinical manifestations and diagnosis</span><span class="headingEndMark"> — </span>Infectious bacterial vulvovaginitis causes vulvar irritation, erythema, pain, and (in some patients) purulent yellow or green vaginal discharge that may be foul smelling. The diagnosis of infectious vulvovaginitis is made by a combination of physical findings and microbiologic testing. Vaginal cultures for respiratory and enteric flora should be obtained at the initial visit if <em>S. pyogenes</em> infection is suspected (see clinical features described below) or if purulent vaginal discharge is present. Cultures are also necessary in prepubertal females with persistent vulvovaginitis despite the institution of hygiene measures. (See <a class="local">'Recurrent or persistent symptoms'</a> above.)</p><p>Specific findings associated with group A streptoccocal, <em>Shigella</em> species, and Enterobiasis (pinworm) infections include: </p><p class="bulletIndent1"><span class="glyph">●</span><strong>Group A streptococcal vaginitis</strong> – Prepubertal females with <em>S. pyogenes</em> vulvovaginitis is characterized by purulent vaginal discharge that is blood-tinged in about half of the cases [<a href="#rid6">6</a>]. Additional symptoms include pruritus, dysuria, or pain. A clinical hallmark of group A streptococcal perineal infection is a fiery or beefy red appearance of the perineal skin, often with a sharp margin  (<a class="graphic graphic_picture graphicRef61877" href="/d/graphic/61877.html" rel="external">picture 1</a>) [<a href="#rid7">7</a>]. Most patients with perineal streptococcal infection do not have symptomatic pharyngitis, but throat cultures are positive in about 75 percent of cases [<a href="#rid6">6</a>]. </p><p></p><p class="bulletIndent1"><em>S. pyogenes</em> is the most common bacterial pathogen in prepubertal females with infectious vulvovaginitis [<a href="#rid2">2,5</a>]. The generally accepted cause of streptococcal vulvovaginitis is autoinoculation from a streptococcal infection at another site, usually the throat [<a href="#rid8">8-10</a>]. Depending upon the definition of vulvovaginitis (vulvitis versus vaginitis only), the prior use of antibiotics, the type of culture obtained (vaginal versus introital), and the clinical setting, approximately 20 percent of females with vulvovaginitis have <em>S. pyogenes</em> [<a href="#rid11">11-15</a>]. Vulvovaginitis may also complicate scarlet fever. (See  <a class="medical medical_review" href="/d/html/8046.html" rel="external">"Complications of streptococcal tonsillopharyngitis", section on 'Scarlet fever'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong><em>Shigella</em></strong><strong> vaginitis</strong> – <em>Shigella</em> infection<strong> </strong>produces mucopurulent and sometimes bloody vaginal discharge and often produces concomitant vulvitis [<a href="#rid16">16,17</a>]. Only about one-fourth of patients have a history of recent or concurrent diarrhea [<a href="#rid17">17</a>]. Nearly all reported cases of this uncommon infection have been caused by <em>Shigella flexneri</em>. Culture of vaginal secretions is necessary to establish the diagnosis; if performed, molecular testing should be confirmed by culture. Stool cultures are generally negative [<a href="#rid16">16,18</a>]. (See  <a class="medical medical_review" href="/d/html/2718.html" rel="external">"Shigella infection: Epidemiology, clinical manifestations, and diagnosis", section on 'Other manifestations'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Enterobiasis</strong> (<strong>pinworms)</strong> – Vulvovaginitis caused by pinworm infection presents with a history of vulvovaginal and anal itching that is worse at night and may be recurrent. Diagnosis can be established by visual inspection of the anal verge or undergarments for mobile worms or microscopic examination of specimens obtained by the paddle test (described separately) or from under the fingernails. (See  <a class="medical medical_review" href="/d/html/5692.html" rel="external">"Enterobiasis (pinworm) and trichuriasis (whipworm)", section on 'Diagnosis'</a>.)</p><p></p><p class="headingAnchor" id="H1957672060"><span class="h2">Management</span></p><p class="headingAnchor" id="H712691348"><span class="h3">Pinworms</span><span class="headingEndMark"> — </span>Pinworms can cause vulvar symptoms such as itching. Children with recurrent episodes of vulvar and/or perianal itching, especially at night, should be examined for pinworms and treated empirically, if indicated. (See  <a class="medical medical_review" href="/d/html/5692.html" rel="external">"Enterobiasis (pinworm) and trichuriasis (whipworm)"</a>.)</p><p class="headingAnchor" id="H2000767039"><span class="h3">Respiratory and enteric flora</span></p><p class="headingAnchor" id="H2804333126"><span class="h4">Group A streptococcal infection</span><span class="headingEndMark"> — </span>Treatment is warranted for all children with vulvovaginitis who have <em>S. pyogenes</em> isolated in culture (either alone or with other organisms). The initial regimen is the same as for streptococcal pharyngitis (ie, oral penicillin or <a class="drug drug_pediatric" data-topicid="12631" href="/d/drug information/12631.html" rel="external">amoxicillin</a> for 10 days; alternative agents for patients with penicillin as shown in the table  (<a class="graphic graphic_table graphicRef115983" href="/d/graphic/115983.html" rel="external">table 2</a>)). A longer course (14 to 21 days) is appropriate for patients with persistent or recurrent infection [<a href="#rid19">19,20</a>]. Treatment of streptococcal pharyngitis is discussed in greater detail separately. (See  <a class="medical medical_review" href="/d/html/8049.html" rel="external">"Treatment and prevention of streptococcal pharyngitis in adults and children"</a>.) </p><p class="headingAnchor" id="H3203040966"><span class="h4">Other respiratory flora</span><span class="headingEndMark"> — </span><em>S. aureus</em>,<em> H. influenzae</em>, and other respiratory flora often resolve with hygiene measures alone as described above but should be treated if vulvovaginitis is persistent or purulent:</p><p class="bulletIndent2"><span class="glyph">•</span><em>S. aureus </em>– Oral antibiotic therapy is prescribed for persistent vaginal discharge using methicillin sensitivity as a guide (eg, <a class="drug drug_pediatric" data-topicid="13138" href="/d/drug information/13138.html" rel="external">cephalexin</a> for methicillin-sensitive <em>S. aureus</em>; oral <a class="drug drug_pediatric" data-topicid="12816" href="/d/drug information/12816.html" rel="external">trimethoprim-sulfamethoxazole</a> for methicillin-resistant <em>S. aureus</em>). If the child also has scattered impetiginous lesions on the vulva and buttocks without vaginitis, topical <a class="drug drug_pediatric" data-topicid="12622" href="/d/drug information/12622.html" rel="external">mupirocin</a> is effective. (See  <a class="medical medical_review" href="/d/html/6027.html" rel="external">"Skin and soft tissue infections in children &gt;28 days: Evaluation and management", section on 'Impetigo or folliculitis'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><em>H. influenzae </em>– Oral beta lactam therapy such as <a class="drug drug_pediatric" data-topicid="12639" href="/d/drug information/12639.html" rel="external">amoxicillin-clavulanate</a>. Alternatives include an oral second- or third-generation cephalosporins and, for patients with penicillin and cephalosporin allergy, macrolides or <a class="drug drug_pediatric" data-topicid="13255" href="/d/drug information/13255.html" rel="external">doxycycline</a>. (See  <a class="medical medical_review" href="/d/html/8048.html" rel="external">"Epidemiology, clinical manifestations, diagnosis, and treatment of <i>Haemophilus influenzae</i>", section on 'Treatment'</a>.)</p><p></p><p>While <em>S. pyogenes</em> should be treated with oral antibiotics, nonspecific vaginitis associated with other respiratory organisms often responds to improved hygiene. Similarly, group B <em>streptococcus</em> may be found as a single organism from the vaginal culture, and symptoms may resolve with hygiene and/or antibiotics.</p><p class="headingAnchor" id="H261582008"><span class="h4">Enteric bacteria</span><span class="headingEndMark"> — </span>Treatment of vulvovaginitis associated with vaginal cultures positive for enteric bacteria depends upon the isolate: </p><p class="bulletIndent1"><span class="glyph">●</span><strong><em>Shigella </em></strong><strong>species </strong>–<strong> </strong>Positive vaginal cultures for <em>Shigella</em> warrant treatment guided by bacterial sensitivities as discussed separately. (See  <a class="medical medical_review" href="/d/html/6003.html" rel="external">"Shigella infection: Treatment and prevention in children", section on 'Oral therapy'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong><em>Yersinia</em></strong><em> </em><strong>species</strong> – Although antimicrobial therapy is not necessary for most patients with enterocolitis caused by <em>Yersinia </em>species, our experience suggests that patients with vulvovaginitis and <em>Yersinia</em> infection will typically not respond to hygiene measures alone and require treatment with oral antibiotics as described separately. (See  <a class="medical medical_review" href="/d/html/3139.html" rel="external">"Yersiniosis: Infection due to Yersinia enterocolitica and Yersinia pseudotuberculosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Other isolates</strong> – Children with vulvovaginitis and enteric bacteria such as <em>E. coli</em>,<em> E. faecalis</em>, <em>K. pneumoniae</em>, <em>Pseudomonas,</em> and <em>P. mirabilis </em>on vaginal culture will usually improve with hygiene measures alone [<a href="#rid2">2-4</a>]. </p><p></p><p class="headingAnchor" id="H3960433393"><span class="h4">Mixed flora</span><span class="headingEndMark"> — </span>A vaginal culture demonstrating mixed flora and no <em>S. pyogenes</em> does not warrant antibiotic therapy. Vulvovaginal hygiene measures are typically sufficient unless vulvovaginitis is persistent or recurrent  (<a class="graphic graphic_table graphicRef132332" href="/d/graphic/132332.html" rel="external">table 1</a>). (See <a class="local">'Recurrent or persistent symptoms'</a> above.)</p><p class="headingAnchor" id="H3415794435"><span class="h3">Sexually transmitted infections</span><span class="headingEndMark"> — </span>STIs in children may result from sexual abuse. Pathogens include <em>Neisseria gonorrhoeae</em>, <em>Chlamydia trachomatis</em>, human papillomavirus (HPV), <em>Treponema pallidum</em>, and herpes simplex virus (HSV). The implications of identification of a sexually transmissible pathogen in a prepubertal child are discussed separately. (See  <a class="medical medical_review" href="/d/html/6605.html" rel="external">"Evaluation of sexual abuse in children and adolescents", section on 'Sexually transmitted infection testing'</a>.)</p><p class="headingAnchor" id="H1341737261"><span class="h4">Neisseria gonorrhoeae</span><span class="headingEndMark"> — </span><em>N. gonorrhoeae</em> usually presents with a green or mucoid vaginal discharge; the infection is rarely asymptomatic [<a href="#rid21">21</a>] but occasionally may be found without symptoms in females being evaluated for sexual abuse.</p><p>The diagnosis is made by culture and/or nonculture methods such as nucleic acid amplification testing (NAAT) in patients with an evident vaginal discharge. In settings where NAAT is accepted as forensic evidence, it may be the preferred testing method. NAAT of urine makes collection of specimens easier as well. (See  <a class="medical medical_review" href="/d/html/6605.html" rel="external">"Evaluation of sexual abuse in children and adolescents", section on 'Prepubertal victims'</a> and  <a class="medical medical_review" href="/d/html/6605.html" rel="external">"Evaluation of sexual abuse in children and adolescents", section on 'Sexually transmitted infections'</a>.)</p><p class="headingAnchor" id="H2459834436"><span class="h4">Chlamydia trachomatis</span><span class="headingEndMark"> — </span><em>C. trachomatis</em> is primarily transmitted to newborns via exposure to an infected mother's genital flora during vaginal birth and may persist for months to several years unless treated with antibiotics (often for another reason). Newborns are less likely to acquire chlamydia at birth than in the past because of the increased screening and treatment of pregnant patients. <em>C. trachomatis</em> is also associated with vaginitis and sexual abuse, although patients may be asymptomatic. (See  <a class="medical medical_review" href="/d/html/4993.html" rel="external">"Chlamydia trachomatis infections in the newborn", section on 'Epidemiology and transmission'</a> and  <a class="medical medical_review" href="/d/html/6605.html" rel="external">"Evaluation of sexual abuse in children and adolescents", section on 'Sexually transmitted infections'</a>.)</p><p class="headingAnchor" id="H2856367724"><span class="h4">Trichomonas vaginalis</span><span class="headingEndMark"> — </span><em>Trichomonas vaginalis</em> can occur in newborns from maternal transmission but is suspicious for sexual abuse in the prepubertal child. (See  <a class="medical medical_review" href="/d/html/6605.html" rel="external">"Evaluation of sexual abuse in children and adolescents", section on 'Sexually transmitted infections'</a> and  <a class="medical medical_review" href="/d/html/5453.html" rel="external">"Trichomoniasis: Clinical manifestations and diagnosis", section on 'Diagnostic evaluation'</a>.)</p><p class="headingAnchor" id="H1576013854"><span class="h4">Condylomata acuminata</span><span class="headingEndMark"> — </span>Condylomata acuminata are skin-colored or pink lesions that may be warty or smooth, flattened papules  (<a class="graphic graphic_picture graphicRef110969" href="/d/graphic/110969.html" rel="external">picture 2</a> and <a class="graphic graphic_picture graphicRef111036" href="/d/graphic/111036.html" rel="external">picture 3</a>). They are caused by HPV. In children younger than two to three years of age, these lesions are likely the result of maternal-child transmission during vaginal birth but may be acquired by sexual or nonsexual transmission. It is not necessary for the mother to be symptomatic or to have a history of HPV for this transmission to occur. HPV testing of mothers does not exclude sexual abuse and therefore is not generally performed. If sexual abuse is of concern, evaluation is needed. (See  <a class="medical medical_review" href="/d/html/6605.html" rel="external">"Evaluation of sexual abuse in children and adolescents", section on 'Sexually transmitted infections'</a>.)</p><p>In older children, sexual transmission and evaluation for potential sexual abuse should be considered, and if there is a concern, children should be interviewed and evaluated by appropriately experienced professionals. Auto- and hetero-inoculation and indirect transmission via fomites are other possibilities. (See  <a class="medical medical_review" href="/d/html/6605.html" rel="external">"Evaluation of sexual abuse in children and adolescents", section on 'Sexually transmitted infections'</a>.)</p><p>The diagnosis is usually made clinically and treated without a biopsy. A biopsy can, however, confirm the presence of HPV and leads to a conclusive diagnosis. HPV DNA typing may help the health care provider formulate a follow-up surveillance plan. There are over 100 distinct HPV subtypes; approximately 40 types are specific for the anogenital epithelium and have varying potentials to cause malignant change, such as cervical or anal cancer. (See  <a class="medical medical_review" href="/d/html/8031.html" rel="external">"Virology of human papillomavirus infections and the link to cancer"</a>.)</p><p>Spontaneous resolution occurs within five years in more than 50 percent of patients [<a href="#rid22">22</a>]. Expectant management is a potential initial approach to asymptomatic pediatric condylomata; however, many families choose to have them treated. Treatment options have not been well studied and include (see  <a class="medical medical_review" href="/d/html/13732.html" rel="external">"Condylomata acuminata (anogenital warts) in children"</a>):</p><p class="bulletIndent1"><span class="glyph">●</span>Laser therapy (requires anesthesia)</p><p class="bulletIndent1"><span class="glyph">●</span>Trichloroacetic acetic (not well tolerated in this age group)</p><p class="bulletIndent1"><span class="glyph">●</span>Topical <a class="drug drug_general" data-topicid="8638" href="/d/drug information/8638.html" rel="external">imiquimod</a> cream (needs careful monitoring to assure vulvar reactions are not severe)</p><p></p><p class="headingAnchor" id="H104621507"><span class="h3">Candida</span><span class="headingEndMark"> — </span>Colonization with <em>Candida</em> occurs in 3 to 4 percent of prepubertal females [<a href="#rid3">3</a>]. <em>Candida</em> infection is uncommon in healthy, toilet-trained prepubertal females, in whom it is frequently over-diagnosed and wrongly assumed to be the etiology of pruritus and the patient's symptoms. Clinicians should avoid antifungal treatment in these patients.</p><p>On the other hand, <em>Candida</em> infection in children who have had recent antibiotic therapy, are immunosuppressed, or who wear diapers does warrant treatment as described separately. In these special circumstances, empiric therapy is appropriate. (See  <a class="medical medical_review" href="/d/html/5452.html" rel="external">"Candida vulvovaginitis: Clinical manifestations and diagnosis"</a> and  <a class="medical medical_review" href="/d/html/5795.html" rel="external">"Diaper dermatitis", section on 'Secondary infection'</a> and  <a class="medical medical_review" href="/d/html/5795.html" rel="external">"Diaper dermatitis"</a>.)</p><p class="headingAnchor" id="H1750772380"><span class="h3">Gardnerella vaginalis</span><span class="headingEndMark"> — </span><em>G. vaginalis</em> is generally not associated with a vaginal discharge in prepubertal females. A possible relationship with sexual abuse has been disputed. In one study, <em>Gardnerella</em> was identified in 14.6 percent of sexually abused females compared with only 4.2 percent of control females [<a href="#rid23">23</a>]. In another report, however, the incidence of <em>Gardnerella</em> was equivalent in sexually abused females and the female children of friends of the author (controls) [<a href="#rid24">24</a>]. If <em>Gardnerella</em> is identified, then a careful history of sexual abuse should be obtained as with any child complaining of vulvovaginal issues. Symptoms may include discharge, odor, itching, and/or rash. Culture is helpful to make a definitive diagnosis, and treatment should then be initiated based on the culture and sensitivity results.</p><p class="headingAnchor" id="H2318074169"><span class="h3">Systemic infections</span><span class="headingEndMark"> — </span>The following systemic infections may have prominent vulvovaginal manifestations:</p><p class="bulletIndent1"><span class="glyph">●</span>Measles – The measles exanthem may involve the vulva and cause local pain and inflammation. (See  <a class="medical medical_review" href="/d/html/3021.html" rel="external">"Measles: Clinical manifestations, diagnosis, treatment, and prevention"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Varicella (chickenpox) – Vulvar vesicular lesions directly cause itching and discomfort and can be a locus for secondarily infection, including group A streptococcal toxic shock syndrome. (See  <a class="medical medical_review" href="/d/html/8284.html" rel="external">"Clinical features of varicella-zoster virus infection: Chickenpox"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Epstein-Barr virus (infectious mononucleosis) – Epstein-Barr virus infection has been associated with acute genital ulceration (Lipschütz ulcer)  (<a class="graphic graphic_picture graphicRef68284" href="/d/graphic/68284.html" rel="external">picture 4</a> and <a class="graphic graphic_picture graphicRef94889" href="/d/graphic/94889.html" rel="external">picture 5</a>). (See  <a class="medical medical_review" href="/d/html/94795.html" rel="external">"Acute genital ulceration (Lipschütz ulcer)"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><em>Mycoplasma pneumoniae</em>-induced rash and mucositis (MIRM) – Painful lesions, primarily vesiculobullous, commonly affect the vulva and vagina in females with MIRM and may interfere with normal voiding. (See  <a class="medical medical_review" href="/d/html/120346.html" rel="external">"Reactive infectious mucocutaneous eruption (RIME)", section on 'Clinical manifestations'</a> and  <a class="medical medical_review" href="/d/html/120346.html" rel="external">"Reactive infectious mucocutaneous eruption (RIME)", section on 'Urogenital lesions'</a>.)</p><p></p><p class="headingAnchor" id="H1858991929"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Nonspecific vulvovaginitis </strong>– Prepubertal females with nonspecific vulvovaginitis typically present with itching, local irritation, and/or odor. Physical examination reveals vulvar irritation with no vaginal discharge, or scant, white or clear, mucoid discharge. Diagnosis is made based on these clinical findings. (See <a class="local">'Clinical manifestations and diagnosis'</a> above.)</p><p></p><p class="bulletIndent1">The approach to treatment is as follows:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Initial treatment</strong> – Start hygiene measures  (<a class="graphic graphic_table graphicRef132332" href="/d/graphic/132332.html" rel="external">table 1</a>); symptoms typically resolve within two to three weeks. (See <a class="local">'Initial treatment'</a> above.)</p><p></p><p class="bulletIndent2">In addition, for children with recurrent episodes of vulvar and/or perianal itching, especially at night, examine for pinworms and treat empirically, as needed. Treatment of pinworm is discussed separately. (See  <a class="medical medical_review" href="/d/html/5692.html" rel="external">"Enterobiasis (pinworm) and trichuriasis (whipworm)"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Persistent or worsening signs or symptoms</strong> – Patients with persistent or worsening signs or symptoms (eg progression to purulent discharge and/or bleeding) require repeat visual inspection of the genitalia in the knee-chest position  (<a class="graphic graphic_figure graphicRef140085" href="/d/graphic/140085.html" rel="external">figure 1</a>) to assess for a vaginal foreign body (see  <a class="medical medical_review" href="/d/html/6450.html" rel="external">"Overview of vulvovaginal conditions in the prepubertal child", section on 'Vaginal foreign body'</a>). If no foreign body is seen, then vaginal culture and testing for sexually transmitted infections (STIs) is indicated. Further treatment is determined by test results:</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Positive culture or testing – Treatment should be provided based upon the specific pathogen as described below.</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Negative culture and testing – For patients with a purulent vaginal discharge, negative vaginal culture (or mixed flora without <em>S. pyogenes</em>), and negative STI testing, we suggest empiric antimicrobial treatment (oral <a class="drug drug_pediatric" data-topicid="12631" href="/d/drug information/12631.html" rel="external">amoxicillin</a> or <a class="drug drug_pediatric" data-topicid="12639" href="/d/drug information/12639.html" rel="external">amoxicillin-clavulanate</a> for 10 days or topical <a class="drug drug_pediatric" data-topicid="12606" href="/d/drug information/12606.html" rel="external">metronidazole</a> or <a class="drug drug_pediatric" data-topicid="13167" href="/d/drug information/13167.html" rel="external">clindamycin</a>) (<a class="grade" href="https://medilib.ir/uptodate/show/grade_6" rel="external">Grade 2C</a>). (See <a class="local">'Recurrent or persistent symptoms'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Chronic discharge</strong> – Prepubertal females with chronic discharge and no clear etiology despite appropriate testing and empiric treatment warrant referral to a pediatric gynecologist or other pediatric specialist with similar expertise to assess for a retained vaginal foreign body and vaginal tumors. (See  <a class="medical medical_review" href="/d/html/6450.html" rel="external">"Overview of vulvovaginal conditions in the prepubertal child"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Infectious vulvovaginitis</strong> – Infectious bacterial vulvovaginitis often causes purulent yellow or green vaginal discharge that may be foul smelling. Prepubertal females with <em>S. pyogenes</em> vulvovaginitis often have a reddened and painful vulva that may be accompanied by serosanguinous vaginal discharge. (See <a class="local">'Clinical manifestations and diagnosis'</a> above.)</p><p></p><p class="bulletIndent1">All patients with infectious vulvovaginitis should start hygiene measures  (<a class="graphic graphic_table graphicRef132332" href="/d/graphic/132332.html" rel="external">table 1</a>). Results of vaginal culture for respiratory and enteric organisms and STI testing guide decisions about antimicrobial therapy:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong><em>S. pyogenes</em></strong><strong> (including when isolated with other organisms)</strong> – Treatment is warranted as for streptococcal pharyngitis and consists of oral penicillin or <a class="drug drug_pediatric" data-topicid="12631" href="/d/drug information/12631.html" rel="external">amoxicillin</a> (alternative agents if penicillin allergy  (<a class="graphic graphic_table graphicRef115983" href="/d/graphic/115983.html" rel="external">table 2</a>)). Patients with persistent or recurrent infection warrant repeat treatment for 14 to 21 days. (See <a class="local">'Group A streptococcal infection'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Other respiratory flora</strong> – For patients with vulvovaginitis that is associated with purulent discharge or is persistent despite ensured hygiene, we suggest antibiotic therapy (<a class="grade" href="https://medilib.ir/uptodate/show/grade_6" rel="external">Grade 2C</a>). The choice of agent is based upon the susceptibility pattern of the isolated organism.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Enteric bacteria</strong> – For females with symptomatic vulvovaginitis, purulent discharge, a<em>nd Shigella</em> <em>or Yersinia</em> species isolated from culture, we suggest antibiotic treatment (<a class="grade" href="https://medilib.ir/uptodate/show/grade_6" rel="external">Grade 2C</a>). The choice of agent is based upon the susceptibility pattern of the isolated organism. For other enteric bacteria, hygiene measures alone are usually sufficient. (See <a class="local">'Enteric bacteria'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Mixed flora and no </strong><strong><em>S. pyogenes</em></strong> – Antimicrobial therapy is not indicated if vaginal foreign body has been definitively ruled out and findings resolve with hygiene measures. Persistent or worsening vulvovaginitis warrants antimicrobial treatment as previously described.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>STIs</strong> – If an STI is identified, appropriate treatment should be provided, and further evaluation and management in consultation with a child abuse specialist and multidisciplinary child protection team is required. Suspected sexual abuse should be reported to Child Protective Services (CPS). (See  <a class="medical medical_review" href="/d/html/6605.html" rel="external">"Evaluation of sexual abuse in children and adolescents"</a> and  <a class="medical medical_review" href="/d/html/6607.html" rel="external">"Management and sequelae of sexual abuse in children and adolescents"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong><em>Candida</em></strong> – <em>Candida</em> infection is an uncommon cause of vaginal discharge or vulvar pruritus in healthy, toilet-trained, prepubertal females. Antifungal treatment should be avoided unless the patient has had recent antibiotic therapy, is immunosuppressed, or wears diapers. Treatment of <em>Candida</em> vulvovaginitis is described separately. (See  <a class="medical medical_review" href="/d/html/115170.html" rel="external">"Candida vulvovaginitis in adults: Treatment of acute infection"</a> and  <a class="medical medical_review" href="/d/html/5795.html" rel="external">"Diaper dermatitis"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Systemic infections</strong> – Vulvovaginal inflammation and mucosal lesions may occur in prepubertal females with systemic infections such as measles, varicella, Epstein-Barr virus, and <em>M. pneumoniae</em>. (See <a class="local">'Systemic infections'</a> above.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Garden AS. Vulvovaginitis and other common childhood gynaecological conditions. Arch Dis Child Educ Pract Ed 2011; 96:73.</a></li><li><a class="nounderline abstract_t">Jarienė K, Drejerienė E, Jaras A, et al. Clinical and Microbiological Findings of Vulvovaginitis in Prepubertal Girls. J Pediatr Adolesc Gynecol 2019; 32:574.</a></li><li><a class="nounderline abstract_t">Alaniz VI, Kobernik EK, George JS, et al. Comparison of Short-Duration and Chronic Premenarchal Vulvar Complaints. J Pediatr Adolesc Gynecol 2021; 34:130.</a></li><li><a class="nounderline abstract_t">Zuckerman A, Romano M. Clinical Recommendation: Vulvovaginitis. J Pediatr Adolesc Gynecol 2016; 29:673.</a></li><li><a class="nounderline abstract_t">Vehapoglu A, Kıyak MC. Clinical Symptoms and Microbiological Findings in Prepubescent Girls with Vulvovaginitis. J Pediatr Adolesc Gynecol 2022; 35:629.</a></li><li><a class="nounderline abstract_t">Straumanis JP, Bocchini JA Jr. Group A beta-hemolytic streptococcal vulvovaginitis in prepubertal girls: a case report and review of the past twenty years. Pediatr Infect Dis J 1990; 9:845.</a></li><li><a class="nounderline abstract_t">Ginsburg CM. Group A streptococcal vaginitis in children. Pediatr Infect Dis 1982; 1:36.</a></li><li><a class="nounderline abstract_t">Colman G, Tanna A, Efstratiou A, Gaworzewska ET. The serotypes of Streptococcus pyogenes present in Britain during 1980-1990 and their association with disease. J Med Microbiol 1993; 39:165.</a></li><li><a class="nounderline abstract_t">Pierce AM, Hart CA. Vulvovaginitis: causes and management. Arch Dis Child 1992; 67:509.</a></li><li><a class="nounderline abstract_t">BOISVERT PL, WALCHER DN. Hemolytic streptococcal vaginitis in children. Pediatrics 1948; 2:24.</a></li><li><a class="nounderline abstract_t">Stricker T, Navratil F, Sennhauser FH. Vulvovaginitis in prepubertal girls. Arch Dis Child 2003; 88:324.</a></li><li><a class="nounderline abstract_t">Ranđelović G, Mladenović V, Ristić L, et al. Microbiological aspects of vulvovaginitis in prepubertal girls. Eur J Pediatr 2012; 171:1203.</a></li><li><a class="nounderline abstract_t">Yilmaz AE, Celik N, Soylu G, et al. Comparison of clinical and microbiological features of vulvovaginitis in prepubertal and pubertal girls. J Formos Med Assoc 2012; 111:392.</a></li><li><a class="nounderline abstract_t">Sikanić-Dugić N, Pustisek N, Hirsl-Hećej V, Lukić-Grlić A. Microbiological findings in prepubertal girls with vulvovaginitis. Acta Dermatovenerol Croat 2009; 17:267.</a></li><li><a class="nounderline abstract_t">Cuadros J, Mazón A, Martinez R, et al. The aetiology of paediatric inflammatory vulvovaginitis. Eur J Pediatr 2004; 163:105.</a></li><li><a class="nounderline abstract_t">Gryngarten MG, Turco ML, Escobar ME, et al. Shigella vulvovaginitis in prepubertal girls. J Pediatr Adolesc Gynecol 1994; 7:86.</a></li><li><a class="nounderline abstract_t">Murphy TV, Nelson JD. Shigella vaginitis: report of 38 patients and review of the literature. Pediatrics 1979; 63:511.</a></li><li><a class="nounderline abstract_t">Bogaerts J, Lepage P, De Clercq A, et al. Shigella and gonococcal vulvovaginitis in prepubertal central African girls. Pediatr Infect Dis J 1992; 11:890.</a></li><li><a class="nounderline abstract_t">Randjelovic G, Otasevic S, Mladenovic-Antic S, et al. Streptococcus pyogenes as the cause of vulvovaginitis and balanitis in children. Pediatr Int 2017; 59:432.</a></li><li><a class="nounderline abstract_t">Hansen MT, Sanchez VT, Eyster K, Hansen KA. Streptococcus pyogenes pharyngeal colonization resulting in recurrent, prepubertal vulvovaginitis. J Pediatr Adolesc Gynecol 2007; 20:315.</a></li><li class="breakAll">Emans SJ, Laufer MR. Pediatric and Adolescent Gynecology, 6th, Lippincott Williams &amp; Wilkins, Philadelphia 2012.</li><li><a class="nounderline abstract_t">Allen AL, Siegfried EC. The natural history of condyloma in children. J Am Acad Dermatol 1998; 39:951.</a></li><li><a class="nounderline abstract_t">Bartley DL, Morgan L, Rimsza ME. Gardnerella vaginalis in prepubertal girls. Am J Dis Child 1987; 141:1014.</a></li><li><a class="nounderline abstract_t">Ingram DL, White ST, Lyna PR, et al. Gardnerella vaginalis infection and sexual contact in female children. Child Abuse Negl 1992; 16:847.</a></li></ol></div><div id="topicVersionRevision">Topic 134115 Version 8.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21119021" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Vulvovaginitis and other common childhood gynaecological conditions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31445141" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Clinical and Microbiological Findings of Vulvovaginitis in Prepubertal Girls.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33246095" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Comparison of Short-Duration and Chronic Premenarchal Vulvar Complaints.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27969009" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Clinical Recommendation: Vulvovaginitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35820605" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Clinical Symptoms and Microbiological Findings in Prepubescent Girls with Vulvovaginitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2263434" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Group A beta-hemolytic streptococcal vulvovaginitis in prepubertal girls: a case report and review of the past twenty years.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6757887" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Group A streptococcal vaginitis in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8366514" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : The serotypes of Streptococcus pyogenes present in Britain during 1980-1990 and their association with disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1580682" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Vulvovaginitis: causes and management.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18874460" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Hemolytic streptococcal vaginitis in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12651758" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Vulvovaginitis in prepubertal girls.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22383074" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Microbiological aspects of vulvovaginitis in prepubertal girls.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22817817" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Comparison of clinical and microbiological features of vulvovaginitis in prepubertal and pubertal girls.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20021979" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Microbiological findings in prepubertal girls with vulvovaginitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14655013" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : The aetiology of paediatric inflammatory vulvovaginitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Shigella vulvovaginitis in prepubertal girls</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/375177" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Shigella vaginitis: report of 38 patients and review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1408494" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Shigella and gonococcal vulvovaginitis in prepubertal central African girls.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27638252" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Streptococcus pyogenes as the cause of vulvovaginitis and balanitis in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17868900" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Streptococcus pyogenes pharyngeal colonization resulting in recurrent, prepubertal vulvovaginitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17868900" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Streptococcus pyogenes pharyngeal colonization resulting in recurrent, prepubertal vulvovaginitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9843007" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : The natural history of condyloma in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3497575" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Gardnerella vaginalis in prepubertal girls.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1486513" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Gardnerella vaginalis infection and sexual contact in female children.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
